Trials / Completed
CompletedNCT03887767
sST2 and Cardiac Surgery
Prognostic Value of sST2 in Cardiac Surgery on Long Term Morbimortality
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 158 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery. The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies
Conditions
Timeline
- Start date
- 2019-03-25
- Primary completion
- 2019-12-01
- Completion
- 2019-12-20
- First posted
- 2019-03-25
- Last updated
- 2020-03-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03887767. Inclusion in this directory is not an endorsement.